Role of cytokines in sustaining long-term human megakaryocytopoiesis in vitro

Blood. 1992 Jan 15;79(2):332-7.

Abstract

An in vitro liquid suspension culture system was used to determine the role of cytokines in sustaining long-term human megakaryocytopoiesis. Bone marrow cells expressing CD34 but not HLA-DR (CD34+DR-) were used as the inoculum of cells to initiate long-term bone marrow cultures (LTBMC). CD34+DR- cells (5 x 10(3)/mL) initially contained 0.0 +/- 0.0 assayable colony-forming unit-megakaryocytes (CFU-MK), 6.2 +/- 0.4 assayable burst-forming unit-megakaryocytes (BFU-MK), and 0.0 +/- 0.0 megakaryocytes (MK). LTBMCs were recharged every 48 hours with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-1 alpha (IL-1 alpha), IL-3, and/or IL-6, alone or in combination. LTBMCs were demidepopulated weekly or biweekly, the number of cells and MK enumerated, and then assayed for CFU-MK and BFU-MK. LTBMCs receiving no cytokine(s) contained no assayable CFU-MK or BFU-MK and no observable MK. LTBMCs receiving GM-CSF, IL-1 alpha, and/or IL-3 contained assayable CFU-MK and MK but no BFU-MK for 10 weeks of culture. The effects of GM-CSF and IL-3, IL-1 alpha and IL-3, but not GM-CSF and IL-1 alpha were additive with regards to their ability to augment the numbers of assayable CFU-MK during LTBMC. LTBMCs supplemented with IL-6 contained modest numbers of assayable CFU-MK for only 4 weeks; this effect was not additive to that of GM-CSF, IL-1 alpha, or IL-3. The addition of GM-CSF, IL-1 alpha, and IL-3 alone or in combination each led to the appearance of significant numbers of MKs during LTBMC. By contrast, IL-6 supplemented cultures contained relatively few MK. These studies suggest that CD34+DR- cells are capable of initiating long-term megakaryocytopoiesis in vitro and that a hierarchy of cytokines exists capable of sustaining this process.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigens, CD / analysis
  • Antigens, CD34
  • Bone Marrow Cells
  • Cells, Cultured
  • Colony-Forming Units Assay
  • Cytokines / pharmacology*
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology
  • HLA-DR Antigens / analysis
  • Hematopoiesis*
  • Hematopoietic Stem Cells / cytology
  • Humans
  • Interleukin-1 / pharmacology
  • Interleukin-3 / pharmacology
  • Interleukin-6 / pharmacology
  • Megakaryocytes / cytology*
  • Megakaryocytes / immunology

Substances

  • Antigens, CD
  • Antigens, CD34
  • Cytokines
  • HLA-DR Antigens
  • Interleukin-1
  • Interleukin-3
  • Interleukin-6
  • Granulocyte-Macrophage Colony-Stimulating Factor